Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.24.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Oct. 31, 2024
Oct. 31, 2023
Net income $ 16,207 $ 31,790
Adjustments to reconcile net income to net cash provided by operating activities:    
Non-cash operating lease expense 5,103 5,506
Foreign currency adjustments (1,234) (566)
Depreciation 41,969 39,756
Deferred income taxes 5,281 6,137
Amortization of deferred financing costs 1,803 1,859
Amortization of intangible assets 15,141 18,910
Stock-based compensation expense 2,394 3,847
Change in fair value of warrant liabilities (130) (6,899)
Net gain on the sale of property, plant and equipment (2,309) (2,247)
Other operating activities (78) 18
Net changes in operating assets and liabilities:    
Receivables 7,164 328
Inventory 600 (1,142)
Other operating assets 632 1,338
Accounts payable (1,679) (464)
Other operating liabilities (3,964) (1,296)
Net cash provided by operating activities 86,900 96,875
Cash flows from investing activities:    
Purchases of property, plant and equipment (43,810) (54,505)
Proceeds from sale of property, plant and equipment 11,679 11,147
Purchases of intangible assets 0 (800)
Net cash used in investing activities (32,131) (44,158)
Cash flows from financing activities:    
Proceeds on revolving loan 313,170 317,989
Payments on revolving loan (332,104) (351,167)
Payment of debt issuance costs (953) (550)
Purchase of treasury stock (10,160) (10,505)
Other financing activities 1,279 (63)
Net cash used in financing activities (28,768) (44,296)
Effect of foreign currency exchange rate changes on cash 1,179 (42)
Net increase in cash and cash equivalents 27,180 8,379
Cash and cash equivalents:    
Beginning of period 15,861 7,482
End of period $ 43,041 $ 15,861